retatrutide latest clinical trial results Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide NEW Phase 3 Clinical

However, this difference was not deemed statistically significant enough to confirm a direct causal relationship

Retatrutide is an investigational peptide medicine currently under clinical evaluation for the treatment of obesity and overweight-related conditions

What is GLP-1 really doing in obesity

We incorporate Ozempic into personalized weight loss plans when appropriate

Here are a few other things worth knowing about how GLP-1s might affect females: More regular periods with PCOS: Some studies suggest that people with PCOS might see their periods become more regular while using GLP-1s, thanks to weight loss and improved hormone balance